Spots Global Cancer Trial Database for multicenter
Every month we try and update this database with for multicenter cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Multicentre Study of Intraoperative Body Temperature Changes in Patients Undergoing Thoracoscopic Radical Surgery for Lung Cancer | NCT04931589 | Body Temperatur... Video-assisted ... Lung Cancer Nursing Caries | - | Second Affiliated Hospital, School of Medicine, Zhejiang University | ||
| T-EUS for Gastrointestinal Disorders: A Multicenter Registry | NCT01522573 | Cholangiocarcin... Pancreatic Canc... Bile Duct Cance... Biliary Strictu... Biliary Obstruc... Stent Obstructi... Proximal Duct S... Distal Duct Str... Ampullary Cance... Biliary Sphinct... Impacted Stones Chronic Pancrea... Peri-ampullary ... Altered Anatomy | EUS guided ERCP | 18 Years - | Weill Medical College of Cornell University | |
| Study to Evaluate Patient Reported Outcome (PRO) and Physical Activity in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Endocrine Therapy or Endocrine Monotherapy | NCT04736576 | Breast Cancer | Wearable device | 20 Years - | Pfizer | |
| Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART) | NCT05012865 | Renal Cell Carc... | avelumab axitinib | 20 Years - | Pfizer | |
| Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia | NCT00493545 | Cervical Intrae... | HspE7 and Poly-... | 18 Years - | Nventa Biopharmaceuticals Corporation | |
| Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer | NCT01516996 | Oropharyngeal C... Hypopharyngeal ... | docetaxel and c... IMRT Nimotuzumab | 18 Years - 70 Years | The Second People's Hospital of Sichuan | |
| Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer | NCT00557206 | Neoplasms Head and Neck N... | Oxaliplatin and... | 18 Years - | Minneapolis Veterans Affairs Medical Center | |
| Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan | NCT05399329 | Breast Cancer | Palbociclib Endocrine thera... | 20 Years - | Pfizer | |
| Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer | NCT01516996 | Oropharyngeal C... Hypopharyngeal ... | docetaxel and c... IMRT Nimotuzumab | 18 Years - 70 Years | The Second People's Hospital of Sichuan | |
| A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients | NCT01305239 | Breast Cancer | Aromasin | 45 Years - | Pfizer | |
| Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) | NCT01736683 | Anemia Myelodysplastic... Chronic Myelomo... Low to Intermed... Myelodysplastic... Chronic Myelomo... | Sotatercept | 18 Years - | Merck Sharp & Dohme LLC | |
| Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry | NCT01439698 | Cholangiocarcin... Pancreatic Canc... Bile Duct Cance... Biliary Strictu... Bile Duct Obstr... | Radio Frequency... | 18 Years - | Weill Medical College of Cornell University | |
| Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2) | NCT05650164 | Renal Cell Carc... | avelumab axitinib | 18 Years - | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | |
| AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours | NCT00819221 | Solid Tumors | AZD2281 liposomal doxor... | 18 Years - 130 Years | AstraZeneca | |
| Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). | NCT04472949 | Small Cell Lung... Lung Cancer | Durvalumab carboplatin etoposide Thoracic radiot... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry | NCT01439698 | Cholangiocarcin... Pancreatic Canc... Bile Duct Cance... Biliary Strictu... Bile Duct Obstr... | Radio Frequency... | 18 Years - | Weill Medical College of Cornell University | |
| Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) | NCT01078415 | Carcinoma, Hepa... | Ablation with t... | 18 Years - | Angiodynamics, Inc. | |
| A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients | NCT01305239 | Breast Cancer | Aromasin | 45 Years - | Pfizer | |
| A Multicentre Study of Intraoperative Body Temperature Changes in Patients Undergoing Thoracoscopic Radical Surgery for Lung Cancer | NCT04931589 | Body Temperatur... Video-assisted ... Lung Cancer Nursing Caries | - | Second Affiliated Hospital, School of Medicine, Zhejiang University | ||
| Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). | NCT04472949 | Small Cell Lung... Lung Cancer | Durvalumab carboplatin etoposide Thoracic radiot... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer | NCT00557206 | Neoplasms Head and Neck N... | Oxaliplatin and... | 18 Years - | Minneapolis Veterans Affairs Medical Center | |
| Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) | NCT01078415 | Carcinoma, Hepa... | Ablation with t... | 18 Years - | Angiodynamics, Inc. | |
| T1 Squamous Cell Carcinomas of the Lip | NCT05610293 | Lip Lip Cancer Lip SCC Squamous Cell C... Squamous Cell C... Surgery Surgical Margin Recurrence Metastasis Tumor Free Marg... | 18 Years - | Maastricht University Medical Center | ||
| Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2 | NCT00149162 | Leukemia | proleukin | - 18 Years | Assistance Publique - Hôpitaux de Paris | |
| Open Versus Laparoscopic Ablation of Liver Malignancies | NCT06304766 | Hepatocellular ... Cholangiocarcin... Liver Metastase... | Laparoscopic ab... Open ablation | 18 Years - | Rigshospitalet, Denmark | |
| Buccal Cancer Resection Ultrasound Guided | NCT05852665 | Buccal Mucosa C... Squamous Cell C... | Ultrasound-guid... | 18 Years - | UMC Utrecht | |
| Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan | NCT05399329 | Breast Cancer | Palbociclib Endocrine thera... | 20 Years - | Pfizer | |
| Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions | NCT02860104 | Neoplasm of Bre... | microwave ablat... | - | Chinese PLA General Hospital | |
| MRI in PROstate Cancer Diagnosis With Prior Risk Assessment | NCT03225222 | Prostate Cancer | biopsy | 50 Years - | Erasmus Medical Center | |
| Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions | NCT02860104 | Neoplasm of Bre... | microwave ablat... | - | Chinese PLA General Hospital | |
| Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation | NCT04137718 | Chinese Non-Small Cell ... | nonIntervention | 18 Years - | Shanghai Pulmonary Hospital, Shanghai, China | |
| Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions | NCT02860104 | Neoplasm of Bre... | microwave ablat... | - | Chinese PLA General Hospital | |
| Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2) | NCT05650164 | Renal Cell Carc... | avelumab axitinib | 18 Years - | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | |
| A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread | NCT05431777 | Urothelial Carc... | Avelumab | 0 Years - | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | |
| T1 Squamous Cell Carcinomas of the Lip | NCT05610293 | Lip Lip Cancer Lip SCC Squamous Cell C... Squamous Cell C... Surgery Surgical Margin Recurrence Metastasis Tumor Free Marg... | 18 Years - | Maastricht University Medical Center | ||
| Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2) | NCT05650164 | Renal Cell Carc... | avelumab axitinib | 18 Years - | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | |
| MRI in PROstate Cancer Diagnosis With Prior Risk Assessment | NCT03225222 | Prostate Cancer | biopsy | 50 Years - | Erasmus Medical Center | |
| MRI in PROstate Cancer Diagnosis With Prior Risk Assessment | NCT03225222 | Prostate Cancer | biopsy | 50 Years - | Erasmus Medical Center | |
| OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer | NCT05949021 | Triple Negative... | Combination of ... | - | Rutgers, The State University of New Jersey |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
